< Return to ENDO Daily Main Page
Inaugural Transatlantic Award Presented to Shlomo Melmed at ENDO 2022
June 11, 2022
The Endocrine Society and European Society of Endocrinology (ESE) presented its inaugural joint Transatlantic Alliance Award to Shlomo Melmed, MB, ChB, at ENDO 2022 on June 11. Melmed also was a featured speaker at ENDO 2022, presenting his talking on “Growth Hormone: An Adult Endocrine Misnomer” at the Presidential Plenary on Health Equity in Endocrinology.
The Transatlantic Alliance Award recognizes an international leader who has made significant advancements in endocrine research in Europe and the U.S. Melmed was chosen for his pioneering research in pituitary medicine and endocrine tumors.
Melmed, executive vice president of Academic Affairs and dean of the Medical Faculty at Cedars-Sinai, Los Angeles, Calif., has pioneered the discovery and application of novel treatments for endocrine tumors. In his National Institutes of Health-funded laboratory, he investigates molecular mechanisms and new treatments for pituitary tumors and related hormonal disorders.
“I am truly humbled to be chosen as the inaugural recipient of this international award,” Melmed says. “For me, this award celebrates all of our Cedars-Sinai physicians and scientists who are working tirelessly to find better ways to treat debilitating chronic diseases.”
Melmed, who also holds the Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine at Cedars-Sinai, has authored more than 350 articles in prestigious peer-reviewed journals. These journal articles include a recent paper in Cell Reports that provides important clues on how local non-pituitary growth hormone is activated in aging colon tissue and initiates the first steps in tumor development.
As a gifted educator, Melmed has also trained more than 80 physicians, scientists and graduate students. He plays a major role in leading the growth of research and educational programs at Cedars-Sinai, which is now one of the nation’s top-tier non-university academic medical centers.
Read the full story in Endocrine News.
< Return to ENDO Daily Main Page
Event Information
June 11-14, 2022Georgia World Congress Center
Atlanta, GA
Important Dates
June 19, 2022- Standard non-member registrant access to the virtual platform concludes
June 30, 2022
- Standard member registrant access to the virtual platform concludes
August 14, 2022
- Standard registration credit claim expiration deadline
December 31, 2022
- Premium member and non-member access to the virtual platform concludes
- Premium registration credit claim expiration deadline